SARMs and method of use thereof
AssigneeUniversity of Tennessee Research Foundation
InventorsJames T. Dalton, Thamarai Ponnusamy, Ramesh Narayanan
Life of this patent
Estimating the term…
Abstract
This invention is directed to substituted acylanilide compounds and uses thereof in treating muscular dystrophies such as Duchenne muscular dystrophy and Becker muscular dystrophy and in improving or preserving lung function and cardiac function in a subject suffering from Duchenne muscular dystrophy.
Claims5
A method of treating, reducing the severity of, reducing the incidence of, delaying the onset of, or reducing the pathogenesis of myotonic dystrophy, limb-girdle muscular dystrophy, facioscapulhumeral muscular dystrophy, congenital muscular dystrophy, oculopharyngeal muscular dystrophy, distal muscular dystrophy, or Emery-Dreifuss muscular dystrophy in a subject in need thereof, consisting essentially of the step of administering to said subject a selective androgen receptor modulator (SARM) compound represented by the structure of formula S-XXIII:
- or its optical isomer, pharmaceutically acceptable salt, or any combination thereof.
Dependencies are inferred from the claim text.